Page last updated: 2024-10-30

mazindol and Allodynia

mazindol has been researched along with Allodynia in 1 studies

Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, P1
Terefenko, EA1
Bray, J1
Deecher, D1
Fensome, A1
Harrison, J1
Kim, C1
Koury, E1
Mark, L1
McComas, CC1
Mugford, CA1
Trybulski, EJ1
Vu, AT1
Whiteside, GT1
Mahaney, PE1

Other Studies

1 other study available for mazindol and Allodynia

ArticleYear
1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.
    Journal of medicinal chemistry, 2009, Sep-24, Volume: 52, Issue:18

    Topics: Administration, Oral; Animals; Behavior, Animal; Benzimidazoles; Biological Transport; Dopamine Plas

2009